---
$id: https://graph.org.ai/products/commodity/51183304
$type: Product
source: UNSPSC
code: "51183304"
title: "Vildagliptin"
class: "51183300"
classTitle: "Antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vildagliptin

**UNSPSC Code**: 51183304
**Class**: [Antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors](Antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protease inhibitor and anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) I6B4B2U96P. European Medicines Agency schedules Vildagliptin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25199. Vildagliptin generally arises in the molecular formula C17H25N3O2. The term VILDAGLIPTIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 18, no. 3, 2004, list 52.) Most nations, for tariff and trade purposes, schedule vildagliptin under HS 29339990 and SITC 51577. As of Q4 2014, VILDAGLIPTIN remains US FDA's Preferred Term for this commodity. Vildagliptin bears US NLM identifiers UMLS ID C1570906 and NCI Concept Code C66653. SMILES: OC12CC3(NCC(=O)N4C(CCC4)C#N)CC(C1)CC(C3)C2.

